LabConnect Unveils SampleGISTICS 2.0: Revolutionizing Clinical Trial Sample Management
LabConnect Introduces SampleGISTICS® 2.0
LabConnect, a global leader in providing central laboratory services and functional service provider solutions for clinical trials, recently announced the debut of SampleGISTICS® 2.0, a cutting-edge application designed to streamline the management of clinical trial samples. This next-generation app allows research sites to quickly scan, record, and transmit participant sample information, effectively replacing the former digital pen technology that LabConnect had employed for years.
With a foundation built on the analysis of millions of samples collected during global clinical trials, SampleGISTICS 2.0 was created to address common issues such as paper-based requisitions, manual data entry, and fragmented courier processes. All of these challenges can lead to sample misplacement, shipment delays, and limited oversight—problems that the developers of SampleGISTICS 2.0 aimed to eliminate.
The CEO of LabConnect, Wes Wheeler, explains, "SampleGISTICS 2.0 is the culmination of over two decades of experience in managing decentralized clinical trials across our extensive network. This wealth of knowledge made it possible for us to develop an application tailored specifically for clinical trials, digitizing sample collection right at the source."
The mobile application offers a user-friendly interface that enhances the experience for research sites, allowing them to handle everything from sample collection and requisitioning to tracking shipments via smartphones or tablets. Key features include barcode scanning, multi-language support, and offline capabilities, ensuring consistent functionality in various site settings while also enabling same-day data collection and enhancing protocol adherence.
Unlike traditional methods that depend on periodic status updates, SampleGISTICS 2.0 provides real-time insights concerning sample locations, statuses, and conditions from the point of collection all the way to laboratory intake. The application offers guided workflows aligned with study protocols, minimizing data entry errors and guaranteeing effective kit usage, which is crucial for downstream shipping and lab processes.
Charles Castano, the Chief Technology Officer at LabConnect, remarked, "SampleGISTICS 2.0 simplifies the way sites manage study visits and participant information at the point of collection, securely transferring it into our validated Laboratory Information Management System (LIMS). By employing technology to enhance data capture at the collection point, we can significantly minimize discrepancies and gain insight into samples nearing their expiration, prioritizing their processing. This results in fewer manual steps, instant sample traceability, and enables real-time data capture, ultimately leading to faster and more reliable lab outcomes."
For more information on SampleGISTICS 2.0, visit LabConnect.com.
About LabConnect
LabConnect is widely recognized as a leading provider of technology-enabled central laboratory services and functional service provider solutions aimed at pharmaceutical, biotechnology, and contract research organizations. The company enhances its operations by connecting laboratories, logistics, technology, and scientific expertise through a decentralized laboratory network model, facilitating the support of clinical trials on a global scale. For additional insights, please check out LabConnect.com.
Topics Health）
【About Using Articles】
You can freely use the title and article content by linking to the page where the article is posted.
※ Images cannot be used.
【About Links】
Links are free to use.